ALFA Filings
Every announcement, straight from the exchange
Every financial results announcement on NSE and BSE that our alert engine sent, newest first.
Time
16,741 announcements
STL Global Ltd reported revenue from operations of ₹20.6 Cr (-24.8% YoY) and a net loss of ₹0.7 Cr for Q4 FY26.
Asian Paints reported FY26 consolidated net sales of ₹35,516 Crore and recommended a ₹23 per share final dividend. Total annual dividend reached ₹27.50 per share.
STL Global Limited reported its audited financial results for the year ended March 31, 2026. The Board approved the statements showing annual revenue from operations of ₹101.51 Crore.
Bharat Global Developers Ltd reported a net loss of ₹1.3 Cr for Q4 FY26.
Tega Industries Ltd reported revenue from operations of ₹526.8 Cr (-1.7% YoY) and net profit of ₹42.7 Cr (-58.1% YoY) for Q4 FY26.
Bharat Global Developers Ltd reported a total annual income of ₹27.19 Crore for FY26. The board approved audited standalone results with an unmodified auditor opinion.
Tega Industries reported consolidated FY26 revenue of ₹1691.94 Crore and recommended a ₹2 per share final dividend. These results reflect consistent performance in mineral beneficiation and mining segments.
Aashka Hospitals Ltd reported revenue from operations of ₹12.6 Cr (+22.3% YoY) and net profit of ₹2.6 Cr (+62.5% YoY) for H2 FY26.
Aashka Hospitals reported a total income of ₹25.28 Crore for the fiscal year ended March 31, 2026. The company also appointed internal and secretarial auditors.
Fine Line Circuits Ltd reported revenue from operations of ₹8.4 Cr (+27.3% YoY) and a net loss of ₹0.2 Cr for Q4 FY26.
Fine-Line Circuits Ltd reported annual total income of ₹33.19 Crore for FY2026. The Board approved audited results with an unmodified auditor opinion during today's meeting.
Gujarat Alkalies & Chemicals Ltd reported revenue from operations of ₹1,125 Cr (+4.6% YoY) and net profit of ₹15 Cr (+70.5% YoY) for Q4 FY26.
Gujarat Alkalies and Chemicals reported FY2025-26 audited financial results and recommended a 177% dividend. The Board also approved a new hydrogen peroxide plant at Dahej.
Premier Synthetics Ltd reported revenue from operations of ₹1.8 Cr (-40.0% YoY) and a net loss of ₹0.5 Cr for Q4 FY26.
Premier Synthetics approved FY26 audited results and ₹17.5 Crore in related party transactions. The board also recommended a 0.01% dividend on redeemable preference shares.
Shri Keshav Cements & Infra Ltd reported revenue from operations of ₹47.3 Cr (+23.2% YoY) and a net loss of ₹9.8 Cr for Q4 FY26.
Sahara Housingfina Corporation Ltd reported revenue from operations of ₹1.9 Cr (-9.5% YoY) and net profit of ₹0.1 Cr (-50.0% YoY) for Q4 FY26.
Shri Keshav Cements reported audited financial results for FY26, including a net loss of Rs. 6.52 Crore. Auditors issued a qualified opinion regarding GST advance payments.
Sahara Housingfina Corporation reported audited FY26 results with total income of ₹7.17 Crore. The Board also approved financial statements with an unmodified auditor opinion.
Ipca Laboratories Ltd reported revenue from operations of ₹2,388 Cr (+6.3% YoY) and net profit of ₹306.7 Cr (+379.2% YoY) for Q4 FY26.
Ipca Laboratories reported FY26 consolidated net profit of ₹1,141.12 Crore. The board recommended a ₹6 per share dividend, signaling strong financial performance and shareholder returns.
Explicit Finance Ltd reported revenue from operations of ₹0.7 Cr (-70.8% YoY) and a net loss of ₹0.1 Cr for Q4 FY26.
Shalimar Wires Industries Ltd reported revenue from operations of ₹38.3 Cr (+5.5% YoY) and net profit of ₹2.3 Cr (+155.6% YoY) for Q4 FY26.
Shalimar Wires Industries reported an annual total income of ₹144.62 Crore for FY26. The board approved audited results with an unmodified auditor opinion.
Explicit Finance Ltd approved its audited FY26 financial results, reporting a total income of ₹327.08 Lakhs. The board concluded the meeting with no further business discussed.
Wealth First Portfolio Managers Ltd reported revenue from operations of ₹16.5 Cr and net profit of ₹10.5 Cr for Q4 FY26.
Wealth First Portfolio Managers approved FY26 audited results and recommended a 10% final dividend. The board also re-appointed internal auditors and increased authorized share capital.
Infinium Pharmachem Ltd reported revenue from operations of ₹105.6 Cr (+45.3% YoY) and net profit of ₹6.5 Cr (+75.7% YoY) for H2 FY26.
Infinium Pharmachem reported a consolidated total income of ₹191.77 Crore for FY26. Net profit stood at ₹12.15 Crore, reflecting steady annual growth.
Capricorn Systems Global Solutions Ltd reported revenue from operations of ₹16.5 Cr (+8150.0% YoY) and net profit of ₹0.2 Cr for Q4 FY26.